VOLORIDGE INVESTMENT MANAGEMENT, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 267 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$4,608,116
+6.8%
172,266
+15.5%
0.02%0.0%
Q4 2023$4,316,401
+52.7%
149,150
+45.5%
0.02%
+21.4%
Q3 2023$2,826,008
+205.6%
102,503
+233.2%
0.01%
+250.0%
Q2 2023$924,616
-45.7%
30,759
-51.9%
0.00%
-63.6%
Q3 2021$1,704,000
+13.6%
63,894
+11.5%
0.01%0.0%
Q1 2021$1,500,000
-54.2%
57,283
-56.0%
0.01%
-59.3%
Q4 2020$3,275,000
+4.9%
130,168
-13.1%
0.03%
+3.8%
Q3 2020$3,122,000
-8.1%
149,800
+4.8%
0.03%
-33.3%
Q2 2020$3,396,000
+40.5%
143,001
+6.4%
0.04%
-43.5%
Q1 2020$2,417,000
+43.0%
134,339
+88.6%
0.07%
+109.1%
Q4 2019$1,690,000
+225.6%
71,229
+277.1%
0.03%
+266.7%
Q3 2019$519,000
-53.2%
18,888
-43.6%
0.01%
-71.0%
Q2 2019$1,109,000
+7.4%
33,516
+13.7%
0.03%0.0%
Q1 2019$1,033,000
-23.9%
29,479
-27.8%
0.03%
-50.0%
Q4 2018$1,357,000
-32.8%
40,842
+21.0%
0.06%
+14.8%
Q2 2018$2,020,000
+59.3%
33,753
+14.8%
0.05%
+68.8%
Q2 2017$1,268,00029,4120.03%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
NEA Management Company, LLC 7,641,250$107,207,0007.06%
HealthInvest Partners AB 782,746$10,982,0006.50%
KOPP INVESTMENT ADVISORS LLC 729,960$10,241,0005.51%
Murphy Michael R 1,028,304$14,427,0004.96%
Opaleye Management Inc. 460,000$6,454,0003.18%
ASHFORD CAPITAL MANAGEMENT INC 511,244$7,173,0001.68%
Bruce & Co., Inc. 394,581$5,535,0001.42%
AlphaOne Investment Services, LLC 235,065$3,297,0001.40%
Ranger Investment Management 1,560,453$21,893,0001.23%
NORTHPOINTE CAPITAL LLC 584,753$8,204,0001.07%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders